HQL
abrdn Life Sciences Investors
HQL
HQL
45 hedge funds and large institutions have $40.7M invested in abrdn Life Sciences Investors in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
45
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$764K | |
| 2 | +$488K | |
| 3 | +$404K | |
| 4 |
NIM
Needham Investment Management
New York
|
+$401K |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$315K |
Top Sellers
| 1 | -$875K | |
| 2 | -$688K | |
| 3 | -$532K | |
| 4 |
Morgan Stanley
New York
|
-$289K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$285K |